Latest filing published 17 Jun 2026 for Edesa Biotech, Inc., €493k.
Pardeep Nijhawan discloses dealings in Edesa Biotech, Inc. to SEC (Form 4). The record holds 26 filings, for trades running from 7 June 2019 to 16 June 2026.
No open-market sale appears; the market trades are 12 purchases worth €92k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.
Half of the purchases are above €6,246 and half below. No cluster: in 12 purchases, no other insider of the company bought within 30 days.
The record was last updated on 17 June 2026 with a transaction (€493k) in Edesa Biotech, Inc. The most recent open-market purchase was published on 29 March 2024, 939 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations